SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
27.00
+0.32 (1.20%)
Mar 9, 2026, 4:00 PM EDT - Market closed
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $899.57 million as of March 9, 2026.
Market Cap
899.57M
Enterprise Value
993.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$27.00
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $899.57M, an increase of 76.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 888.91M | 0.98% |
| Mar 5, 2026 | 880.25M | -0.97% |
| Mar 4, 2026 | 888.91M | -0.26% |
| Mar 3, 2026 | 891.24M | 0.07% |
| Mar 2, 2026 | 890.57M | -4.54% |
| Feb 27, 2026 | 932.89M | -1.23% |
| Feb 26, 2026 | 944.55M | -2.68% |
| Feb 25, 2026 | 970.54M | -0.55% |
| Feb 24, 2026 | 975.87M | -0.20% |
| Feb 23, 2026 | 977.87M | 0.10% |
| Feb 20, 2026 | 976.87M | -1.21% |
| Feb 19, 2026 | 988.86M | 4.14% |
| Feb 18, 2026 | 949.55M | 2.93% |
| Feb 17, 2026 | 922.56M | -1.88% |
| Feb 13, 2026 | 940.22M | 2.62% |
| Feb 12, 2026 | 916.23M | -0.18% |
| Feb 11, 2026 | 917.89M | -1.01% |
| Feb 10, 2026 | 927.22M | 6.30% |
| Feb 9, 2026 | 872.25M | 70.84% |
| Feb 6, 2026 | 510.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 928.01M |
| Valneva SE | 920.15M |
| Arbutus Biopharma | 907.77M |
| SELLAS Life Sciences Group | 904.20M |
| Evommune | 900.82M |
| Fortrea Holdings | 896.67M |
| ARS Pharmaceuticals | 879.75M |
| KalVista Pharmaceuticals | 873.44M |